Prostate CancerTools for Diagnosing Prostate Cancer
Frank dela Rama explains the options available today, the limitations, and possibilities in the future for the diagnosis of prostate cancer.
Video Library – March 6, 2019 Clinical Nurse Specialist,
Oncology/Genomics
CANCER CARE Palo Alto
Medical Foundation
Palo Alto, CA
Frank dela Rama explains the options available today, the limitations, and possibilities in the future for the diagnosis of prostate cancer.
Recommended For You
FDA Approvals, News & UpdatesProstate CancerIn December 2020, the FDA approved Orgovyx (relugolix), as the first oral hormone therapy for the treatment of men with advanced prostate cancer. This new drug may eliminate the need to visit the clinic for treatment, helping patients with cancer avoid unnecessary exposure during the pandemic.
Prostate CancerHere are the drugs and financial support services available to patients receiving treatment for Prostate Cancer.
Prostate CancerThe PARP inhibitor Lynparza (olaparib), a type of drug that is usually used for the treatment of women with ovarian cancer, has also been studied in men with prostate cancer. The results of the PROfound clinical trial were recently presented at the 2020 ASCO annual meeting by Antoine Thiery-Vuillemin, MD, PhD, Centre Hospitalier de Besançon, France.
Prostate CancerResults of a new study showed that the combination of Cabometyx (cabozantinib) and the immune checkpoint inhibitor Tecentriq (atezolizumab) was safe and effective in men with metastatic (spreading) castration-resistant prostate cancer, the most common type of prostate cancer.
Last modified: March 19, 2019
